UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Recent advances in the total synthesis of galantamine, a natural medicine for Alzheimer's disease

Natural product reports, 2024-07, Vol.41 (7), p.16-19

2024

Volltextzugriff (PDF)

Combination Drug Therapy for the Management of Alzheimer's Disease

International journal of molecular sciences, 2020-05, Vol.21 (9), p.3272

2020

Volltextzugriff (PDF)

Treating disorders across the lifespan by modulating cholinergic signaling with galantamine

Journal of neurochemistry, 2021-09, Vol.158 (6), p.1359-1380

2021

Volltextzugriff (PDF)

Static Binding and Dynamic Transporting‐Based Design of Specific Ring‐Chain‐Ring Acetylcholinesterase Inhibitor: From Galantamine to Natural Product

Chemistry : a European journal, 2023-05, Vol.29 (25), p.e202203363-n/a

2023

Volltextzugriff (PDF)

The involvement of neuroinflammation in an animal model of dementia and depression

Progress in neuro-psychopharmacology & biological psychiatry, 2024-07, Vol.133, p.110999-110999, Article 110999

2024

Volltextzugriff (PDF)

Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity

Bioorganic & medicinal chemistry, 2015-09, Vol.23 (17), p.5382-5389

2015

Volltextzugriff (PDF)

Galantamine-loaded solid-lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations

Drug delivery, 2016-05, Vol.23 (4), p.1434-1443

2016

Volltextzugriff (PDF)

Targeting α7-nAChR by galantamine mitigates reserpine-induced fibromyalgia-like symptoms in rats: Involvement of cAMP/PKA, PI3K/AKT, and M1/M2 microglia polarization

European journal of pharmacology, 2023-08, Vol.952, p.175810-175810, Article 175810

2023

Volltextzugriff (PDF)

Chemical and Biological Aspects of Montanine-Type Alkaloids Isolated from Plants of the Amaryllidaceae Family

Molecules (Basel, Switzerland), 2020-05, Vol.25 (10), p.2337

2020

Volltextzugriff (PDF)

Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDM

Scientific reports, 2022-03, Vol.12 (1), p.4451-4451, Article 4451

2022

Volltextzugriff (PDF)

Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease

PloS one, 2014-02, Vol.9 (2), p.e89454-e89454

2014

Volltextzugriff (PDF)

The Cholinergic Drug Galantamine Alleviates Oxidative Stress Alongside Anti-inflammatory and Cardio-Metabolic Effects in Subjects With the Metabolic Syndrome in a Randomized Trial

Frontiers in immunology, 2021-03, Vol.12, p.613979-613979

2021

Volltextzugriff (PDF)

Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach

Molecules (Basel, Switzerland), 2023-01, Vol.28 (3), p.1035

2023

Volltextzugriff (PDF)

Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors

Molecules (Basel, Switzerland), 2020-07, Vol.25 (15), p.3341

2020

Volltextzugriff (PDF)

Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway

Brain, behavior, and immunity, 2009-01, Vol.23 (1), p.41-45

2009

Volltextzugriff (PDF)

A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders

Molecules (Basel, Switzerland), 2021-03, Vol.26 (7), p.1865

2021

Volltextzugriff (PDF)

Palladium-Catalyzed Synthesis, Acetylcholinesterase Inhibition, and Neuroprotective Activities of N‑Aryl Galantamine Analogues

Journal of natural products (Washington, D.C.), 2023-04, Vol.86 (4), p.939-946

2023

Volltextzugriff (PDF)

A Comparative Study between Lycorine and Galantamine Abilities to Interact with AMYLOID β and Reduce In Vitro Neurotoxicity

International journal of molecular sciences, 2023-01, Vol.24 (3), p.2500

2023

Volltextzugriff (PDF)

Galanthamine, Plicamine, and Secoplicamine Alkaloids from Zephyranthes candida and Their Anti-acetylcholinesterase and Anti-inflammatory Activities

Journal of natural products (Washington, D.C.), 2016-04, Vol.79 (4), p.760-766

2016

Volltextzugriff (PDF)

Galantamine ameliorates experimental pancreatitis

Molecular medicine (Cambridge, Mass.), 2023-10, Vol.29 (1), p.149-149, Article 149

2023

Volltextzugriff (PDF)

Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics

Future medicinal chemistry, 2016-04, Vol.8 (6), p.697-711

2016

Volltextzugriff (PDF)

Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice

Current drug delivery, 2019-01, Vol.16 (1), p.51-58

2019

Volltextzugriff (PDF)

Free energy, precision and learning: the role of cholinergic neuromodulation

The Journal of neuroscience, 2013-05, Vol.33 (19), p.8227-8236

2013

Volltextzugriff (PDF)

Galantamine-loaded PLGA nanoparticles, from nano-emulsion templating, as novel advanced drug delivery systems to treat neurodegenerative diseases

Nanoscale, 2015-07, Vol.7 (28), p.12076-12084

2015

Volltextzugriff (PDF)

Sweroside Ameliorated Memory Deficits in Scopolamine-Induced Zebrafish ( Danio rerio ) Model: Involvement of Cholinergic System and Brain Oxidative Stress

Molecules (Basel, Switzerland), 2022-09, Vol.27 (18), p.5901

2022

Volltextzugriff (PDF)

1 – 25 von 1.161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.011)
Mit Volltextzugriff
(796)

Publikationsform

Sprache

8 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(912)
Life Sciences & Biomedicine
(876)
Galantamine
(569)
Humans
(564)
Galantamine - Pharmacology
(562)
Pharmacology & Pharmacy
(541)
Animals
(529)
Cholinesterase Inhibitors - Pharmacology
(392)
Male
(392)
Alzheimer's Disease
(373)
Alzheimer Disease - Drug Therapy
(311)
Biological And Medical Sciences
(299)
Medical Sciences
(275)
Galantamine - Therapeutic Use
(262)
Neurosciences & Neurology
(250)
Cholinesterase Inhibitors - Therapeutic Use
(240)
Pharmacology. Drug Treatments
(240)
Female
(234)
Rats
(226)
Neurosciences
(200)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Recent advances in the total synthesis of galantamine, a natural medicine for Alzheimer's disease

Combination Drug Therapy for the Management of Alzheimer's Disease

Treating disorders across the lifespan by modulating cholinergic signaling with galantamine

Static Binding and Dynamic Transporting‐Based Design of Specific Ring‐Chain‐Ring Acetylcholinesterase Inhibitor: From Galantamine to Natural Product

The involvement of neuroinflammation in an animal model of dementia and depression

Galantamine derivatives with indole moiety: Docking, design, synthesis and acetylcholinesterase inhibitory activity

Galantamine-loaded solid-lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations

Targeting α7-nAChR by galantamine mitigates reserpine-induced fibromyalgia-like symptoms in rats: Involvement of cAMP/PKA, PI3K/AKT, and M1/M2 microglia polarization

Chemical and Biological Aspects of Montanine-Type Alkaloids Isolated from Plants of the Amaryllidaceae Family

Analysis of treatment pattern of anti-dementia medications in newly diagnosed Alzheimer's dementia using OMOP CDM

Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease

The Cholinergic Drug Galantamine Alleviates Oxidative Stress Alongside Anti-inflammatory and Cardio-Metabolic Effects in Subjects With the Metabolic Syndrome in a Randomized Trial

Galantamine Based Novel Acetylcholinesterase Enzyme Inhibitors: A Molecular Modeling Design Approach

Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors

Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway

A Novel Galantamine-Curcumin Hybrid as a Potential Multi-Target Agent against Neurodegenerative Disorders

Palladium-Catalyzed Synthesis, Acetylcholinesterase Inhibition, and Neuroprotective Activities of N‑Aryl Galantamine Analogues

A Comparative Study between Lycorine and Galantamine Abilities to Interact with AMYLOID β and Reduce In Vitro Neurotoxicity

Galanthamine, Plicamine, and Secoplicamine Alkaloids from Zephyranthes candida and Their Anti-acetylcholinesterase and Anti-inflammatory Activities

Galantamine ameliorates experimental pancreatitis

Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics

Nose to Brain Delivery of Galantamine Loaded Nanoparticles: In-vivo Pharmacodynamic and Biochemical Study in Mice

Free energy, precision and learning: the role of cholinergic neuromodulation

Galantamine-loaded PLGA nanoparticles, from nano-emulsion templating, as novel advanced drug delivery systems to treat neurodegenerative diseases

Sweroside Ameliorated Memory Deficits in Scopolamine-Induced Zebrafish ( Danio rerio ) Model: Involvement of Cholinergic System and Brain Oxidative Stress

Suchergebnisse filtern